VectivBio Company

VectivBio is a biotechnology company that focuses on developing transformational medicines for patients with serious rare diseases. They aim to target well-defined biology with best-in-disease therapies that can significantly improve the lives of patients and their families. The company was founded in 2019 as a spinout from Therachon and is based in Basel, Switzerland. Their focus is on discovering, developing, and commercializing innovative treatments for severe rare conditions with high unmet medical needs.

Connections from